🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to identify preventive treatments that can min...
Status
Recruiting
Location
University of California San Francisco
Start Date
2024-08-26
Trial ID
NCT06500884
Treatments Being Tested
The purpose of this study is to see whether combination treatment of Teclis...
Status
Recruiting
Location
University of Miami
Start Date
2023-12-04
Trial ID
NCT06100237
Treatments Being Tested
Multiple myeloma is characterized by a pattern of recurrent relapse and rem...
Status
Recruiting
Location
Yale University
Start Date
2025-08-21
Trial ID
NCT06993675
Treatments Being Tested
This is a single-arm, open-label, phase 1b study evaluating the safety and ...
Status
Recruiting
Location
Froedtert & the Medical College of Wisconsin
Start Date
2025-12-02
Trial ID
NCT07093554
Treatments Being Tested
Multiple myeloma is a type of blood cancer that can come back even after ef...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09
Trial ID
NCT07740486
Treatments Being Tested
The purpose of this research is to learn whether using teclistamab and talq...
Status
Not Yet Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2026-07-01
Trial ID
NCT07029776
The purpose of this study is to characterize the safety of Talquetamab and ...
Status
Active Not Recruiting
Location
University of Alabama Birmingham
Start Date
2017-12-16
Trial ID
NCT03399799
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of talquet...
Status
Recruiting
Location
University of Alabama Birmingham
Start Date
2021-02-01
Trial ID
NCT04634552
Treatments Being Tested
The purpose of this study is to compare the efficacy of teclistamab in comb...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2022-10-25
Trial ID
NCT05552222
Treatments Being Tested
The purpose of this study is to compare the efficacy of talquetamab versus ...
Status
Withdrawn
Location
University of Arkansas for Medical Sciences
Start Date
2022-10-20
Trial ID
NCT05461209
Treatments Being Tested